
Opinion|Videos|April 25, 2024
Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer
GU medical oncologist Dr. Rana McKay and urologist Dr. Neal Shore explore how predictive biomarkers and genetic testing are informing risk assessment and guiding personalized treatment decisions in clinical practice.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance
2
Taylor Goodstein, MD, highlights contemporary experience with gene therapies for NMIBC
3
Real-World Evidence in mCSPC Management
4
Jim Hu, MD, discusses new posterior approach to nerve-sparing prostatectomy
5



















